Loading...
Danaher Community
NYSE:DHR Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 114 Fair Values set on narratives written by author
Community Investing Ideas
DHR: Premium Outlook Will Be Sustained As Market Recovery Gradually Unfolds
Key Takeaways Strong recurring revenue and margin stability are driven by consumables, services, and robust demand for advanced diagnostics and life science tools. Innovation in precision medicine and disciplined operational execution position the company for high-margin growth and expanding global market opportunities.Read more
0users have liked this narrative
0users have commented on this narrative
61users have followed this narrative
AN
US$254.4
13.0% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
5.48% p.a.
Profit Margin
19.9%
Future PE
37.13x
Share price in 2028
US$318.5